NATERA, INC. Increase (Decrease) in Restricted Cash for Operating Activities
NATERA, INC. (NTRA) reported Increase (Decrease) in Restricted Cash for Operating Activities of -$1.03 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2018-03-15
- NATERA, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-12-31 was $14.00K.
- NATERA, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-09-30 was -$719.00K.
- NATERA, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-06-30 was -$11.00K.
- NATERA, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2017-03-31 was -$317.00K, a 501.27% decline year-over-year.
- NATERA, INC. increase (decrease) in restricted cash for operating activities for fiscal 2017 was -$1.03M.
- NATERA, INC. increase (decrease) in restricted cash for operating activities for fiscal 2016 was -$150.00K, a 154.95% decline from fiscal 2015.
- NATERA, INC. increase (decrease) in restricted cash for operating activities for fiscal 2015 was $273.00K.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$705.00K derived: sum of 2 quarters · filed 2018-03-15 | -$716.00K derived: sum of 3 quarters · filed 2018-03-15 | -$1.03M 10-K · filed 2018-03-15 |
| 2017-09-30 | -$719.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$730.00K derived: sum of 2 quarters · filed 2017-11-09 | -$1.05M 10-Q · filed 2017-11-09 | -$1.14M derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$328.00K 10-Q · filed 2017-08-09 | -$424.00K derived: sum of 3 quarters · filed 2018-03-15 | -$510.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-03-31 | -$317.00K 10-Q · filed 2017-05-10 | -$413.00K derived: sum of 2 quarters · filed 2018-03-15 | -$499.00K derived: sum of 3 quarters · filed 2018-03-15 | -$546.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-12-31 | -$96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$182.00K derived: sum of 2 quarters · filed 2018-03-15 | -$229.00K derived: sum of 3 quarters · filed 2018-03-15 | -$150.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$133.00K derived: sum of 2 quarters · filed 2017-11-09 | -$54.00K 10-Q · filed 2017-11-09 | -$84.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $32.00K 10-Q · filed 2017-08-09 | $2.00K derived: sum of 3 quarters · filed 2018-03-15 | $43.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $79.00K 10-Q · filed 2017-05-10 | $49.00K derived: sum of 2 quarters · filed 2018-03-15 | $90.00K derived: sum of 3 quarters · filed 2018-03-15 | $318.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $11.00K derived: sum of 2 quarters · filed 2018-03-15 | $239.00K derived: sum of 3 quarters · filed 2018-03-15 | $273.00K 10-K · filed 2018-03-15 |
| 2015-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $269.00K derived: sum of 2 quarters · filed 2016-11-14 | $303.00K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $262.00K 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $34.00K 10-Q · filed 2016-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |